Is Prevest Denpro Ltd (543363) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Prevest Denpro Ltd is a good quality company .

Is Prevest Denpro Ltd (543363) undervalued or overvalued?

The key valuation ratios of Prevest Denpro Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is Prevest Denpro Ltd (543363) share price return in the past 10 years?

Data is not available for this company

Is Prevest Denpro Ltd (543363) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Prevest Denpro Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Prevest Denpro Ltd (543363)?

Company share prices are keep on changing according to the market conditions. The current trading price of Prevest Denpro Ltd (543363) on 17-Apr-2026 16:59:59 at 16:59 is 452.55.

What is the P/E ratio of Prevest Denpro?

The latest standalone P/E ratio of Prevest Denpro as of 17-Apr-2026 is 26.37.

What is the P/B ratio of Prevest Denpro Ltd (543363)?

The latest standalone P/B ratio of Prevest Denpro Ltd (543363) as of 17-Apr-2026 is 4.49.

What is the 52-week high and low of Prevest Denpro Ltd (543363)?

The 52-week high of Prevest Denpro Ltd (543363) is Rs. 622.05 and the 52-week low is Rs. 318.15.

Prevest Denpro Ltd (543363) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Prevest Denpro Ltd (543363)
Brand: Prevest Denpro

Prevest Denpro Ltd (543363) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Prevest Denpro Ltd (543363)

BSE: 543363 NSE:

Key Metrics

Market Cap

₹543 Cr.

P/E Ratio

26.37

Price to Book (P/B)

4.49

Price to Sales (P/S)

7.62

EV/EBITDA

16.04

Return on Capital Employed (ROCE)

25.26%

Current Price

₹452.6

Return on Equity (ROE)

18.74%

Return on Assets (ROA)

17.54%

Operating Profit Margin

35.4%

Net Profit Margin

28.86%

Gross Profit Margin

40.3%

Book Value per Share

₹100.8

Sales Growth (YoY)

11.75%

Sales Growth (3 Years)

18.28%

Operating Profit Growth (1 Year)

11.38%

Operating Profit Growth (3 Years)

13.61%

Net Profit Growth (1 Year)

12.9%

52-Week Low / High

₹318 / 622

Net Profit Growth (3 Years)

16.31%

Dividend Yield

0.23%

Promoter Holding

73.60%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Prevest Denpro Ltd?

Prevest Denpro Ltd revenue growth is 11.8% for FY-2025 , which is below its 5 year CAGR of 22.6% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Prevest Denpro Ltd?

Promoters hold 73.60% of the Prevest Denpro Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Prevest Denpro Ltd vs industry peers?

Prevest Denpro Ltd revenue CAGR is 22.60% , compared to the industry median CAGR of 1.45% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Prevest Denpro Ltd belong to?

Prevest Denpro Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.

Q.1 Stock return of Prevest Denpro Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of 11.49% based on the current price.

DeciZen - make an informed investing decision on Prevest Denpro

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Prevest Denpro stock performance

Key Ratios

Is Prevest Denpro Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	37.2%	39.3%	45.6%	47%	39.6%	32.3%	26.8%	25.3%	-
Value Creation Index ⓘ	1.7	1.8	2.3	2.4	1.8	1.3	0.9	0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	17	19.3	22.8	28.5	38.1	49.9	56.4	63.1	71
Sales YoY Gr.	-	13.6%	18.1%	25.1%	33.8%	30.8%	13.2%	11.8%	-
Adj EPS ⓘ	2.4	3.3	5.6	8	9.5	12.9	13.2	15	17.2
YoY Gr.	-	39.5%	68.4%	43.1%	18.3%	35.8%	3%	13.1%	-
BVPS (₹) ⓘ	8.3	11.7	17.3	25.5	47.6	60.7	73.8	88	100.8
Adj Net Profit ⓘ	2.1	2.9	4.9	7.1	11.4	15.4	15.9	18	21
Cash Flow from Ops. ⓘ	2.4	3	4.7	8.8	7	10.4	11.5	15	-
Debt/CF from Ops. ⓘ	0.5	0.5	0.4	0.2	0.2	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	22.6%	18.3%	11.8%
Adj EPS ⓘ	NA	21.8%	16.6%	13.1%
BVPSⓘ	NA	38.4%	22.8%	19.2%
Share Price	-	-	12.5%	-13.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	28.8	33.3	38.6	37.4	28.6	23.8	19.7	18.5	18.2
Op. Profit Mgn % ⓘ	18	20.1	22.8	31.7	39.9	39.7	35.5	35.4	35.2
Net Profit Mgn % ⓘ	12.4	15.2	21.7	24.8	29.8	31	28.2	28.5	28.9
Debt to Equity ⓘ	0.2	0.1	0.1	0.1	0	0	0	0	-
Working Cap Days ⓘ	0	69	74	75	76	85	100	107	219
Cash Conv. Cycle ⓘ	0	14	19	-4	-2	32	58	70	204

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	17.2	16.5
TTM Sales (₹ Cr.)	71.3	71.3
BVPS (₹) ⓘ	100.8	100.2
Reserves (₹ Cr.) ⓘ	109	108
P/BV ⓘ	4.49	4.52
PE ⓘ	26.37	27.42

From the Market
52 Week Low / High (₹)	318.15 / 622.05
All Time Low / High (₹)	170.65 / 686.00
Market Cap (₹ Cr.)	543
Equity (₹ Cr.)	12
Face Value (₹)	10
Industry PE ⓘ	163.7

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Prevest Denpro - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	17	19	23	28	38	50	56	63
Operating Expenses ⓘ +	14	15	18	19	23	30	36	41
Manufacturing Costs	1	1	1	0	0	0	1	1
Material Costs	5	6	7	8	10	13	14	14
Employee Cost	3	3	5	3	4	5	6	6
Other Costs ⓘ	5	5	5	8	9	12	16	20
Operating Profit ⓘ	3	4	5	9	15	20	20	22
Operating Profit Margin (%)	17.4%	20.1%	22.8%	31.7%	39.9%	39.7%	35.5%	35.4%
Other Income ⓘ +	1	0	2	1	2	2	3	4
Exceptional Items ⓘ	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	1	1	1	2
Profit Before Tax ⓘ	3	4	6	9	16	21	21	24
Tax ⓘ	1	1	1	2	4	5	5	6
Profit After Tax	2	3	5	7	12	16	16	18
PAT Margin (%)	12.8%	15.5%	22.0%	25.3%	30.4%	31.5%	28.6%	28.9%
Adjusted EPS (₹)	2.5	3.4	5.7	8.2	9.6	13.1	13.4	15.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	8%	7%	7%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	7	10	15	22	57	73	89	106
Share Capital ⓘ	0	0	0	0	12	12	12	12
Reserves ⓘ	7	10	15	22	45	61	77	94
Debt +	1	1	2	1	1	0	0	0
Long Term Debt	1	1	2	1	1	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0
Trade Payables	1	1	1	4	2	1	1	2
Others Liabilities ⓘ	2	2	3	3	4	4	5	5
Total Liabilities ⓘ	11	15	21	31	64	79	95	113
Fixed Assets
Net Fixed Assets ⓘ +	4	5	5	5	7	7	27	27
Gross Block	6	8	8	9	11	12	33	35
Accumulated Depreciation	2	3	3	4	4	5	6	8
CWIP ⓘ	0	0	0	2	5	17	0	0
Investments ⓘ	0	0	0	0	1	1	2	5
Inventories	0	0	1	1	3	5	6	8
Trade Receivables	2	2	2	4	2	4	8	8
Cash Equivalents ⓘ	4	6	10	16	42	39	48	60
Others Assets ⓘ	1	1	2	2	4	5	4	5
Total Assets ⓘ	11	15	21	31	64	79	95	113

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	2	3	5	9	7	10	11	15
PBT ⓘ	3	4	6	9	16	21	21	24
Adjustment ⓘ	1	0	0	0	-1	-1	-1	-2
Changes in Working Capital ⓘ	-1	-0	-1	1	-4	-4	-4	-1
Tax Paid ⓘ	-1	-1	-1	-2	-4	-5	-5	-6
Cash Flow From Investing Activity ⓘ +	-1	-1	-1	-2	-4	-12	-2	-2
Capex	-1	-1	-1	-2	-5	-14	-4	-2
Net Investments	0	-0	-0	-0	-0	-0	-1	-3
Others ⓘ	0	0	0	1	1	2	2	4
Cash Flow From Financing Activity ⓘ +	-0	0	0	-1	23	-1	-0	-1
Net Proceeds from Shares ⓘ	0	0	0	0	23	0	0	0
Net Proceeds from Borrowing ⓘ	-0	0	0	-0	-0	-1	0	0
Interest Paid ⓘ	-0	-0	-0	-0	-0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	-0	-1
Others ⓘ	0	-0	0	-0	0	0	0	0
Net Cash Flow ⓘ	1	2	4	6	26	-3	9	12

Finance Ratio

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	29.72	34.02	39.13	38.13	29.07	24.19	19.98	18.74
ROCE (%)	37.15	39.27	45.63	46.96	39.64	32.25	26.8	25.26
Asset Turnover Ratio	1.54	1.49	1.28	1.12	0.83	0.71	0.67	0.63
PAT to CFO Conversion(x)	1	1	1	1.29	0.58	0.63	0.69	0.83
Working Capital Days
Receivable Days	32	37	36	37	28	24	39	45
Inventory Days	10	9	13	15	21	29	34	40
Payable Days	72	64	69	122	105	44	35	38

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Prevest Denpro Ltd FAQs

The current trading price of Prevest Denpro on 17-Apr-2026 16:59 is ₹452.6.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Prevest Denpro stood at ₹543.2 Cr

The latest P/E ratio of Prevest Denpro as of 16-Apr-2026 is 26.37.

The latest P/B ratio of Prevest Denpro as of 16-Apr-2026 is 4.49.

The 52-week high of Prevest Denpro is ₹622.0 and the 52-week low is ₹318.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Prevest Denpro is ₹71.30 ( Cr.) .

About Prevest Denpro Ltd

The company develops, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The breadth and depth of its product offerings address majority of the dentists’ clinical needs for consumable dental materials. Its product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables. Its products are sold in the regions of Europe, Asia, South America, Middle East and Africa. Further, as per its diversification plans, the company is currently expanding its existing manufacturing unit by setting up another manufacturing facility for manufacturing new line of products that will include hygiene products (sanitizers and disinfectants), oral hygiene products (mouth washes and mouth rinses), oral care products(medicated ointments, gels and creams for dental treatment) and biomaterials (i.e. bone augmentation materials). The proposed facility will be well-equipped with latest machineries.

Business area of the company

The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.

Key events and milestones

1999: Incorporation of the Company.
2000: First Manufacturing unit was established at Digiana, Jammu, J&K.
2011: Second Manufacturing unit was established at Samba, J&K.
2014-15: Crossed Turnover of Rs 10 crore.
2016: Won Sushruta award for Best Dental Manufacture by the Indian Dental Association’s.
2016: Received Certificate for ‘Best Enterprise’ in the field of manufacture of dental materials, India by the Socrates Committee, Oxford, UK.
2017: Shifted manufacturing operations from First Manufacturing Unit to Second Manufacturing unit.
2017: Won “Northern Region Export Excellence Award” - Gold Trophy for outstanding export performance in the category of top exporter J&K - SME by FIEO (2017).
2019-20: Crossed Turnover of Rs 20 crore.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Prevest Denpro Ltd (543363) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Prevest Denpro Share Price